Taro Pharmaceutical Industries Ltd represents a commitment to delivering high-quality pharmaceutical products to patients worldwide. The company's corporate philosophy centers around innovation, quality, and customer satisfaction. Taro is dedicated to investing in research and development to bring innovative healthcare solutions to market. With a focus on excellence, Taro upholds strict quality standards throughout its manufacturing processes. The company strives to enhance patients' well-being by providing a diverse portfolio of affordable and accessible medications. Taro Pharmaceutical Industries Ltd prioritizes ethical practices, integrity, and transparency in its operations, ensuring trust and reliability in the pharmaceutical industry.

Taro Pharmaceutical Industries Ltd is primarily present in various countries and regions around the world. As a global pharmaceutical company, Taro operates in multiple markets, including the United States, Canada, Europe, Israel, and other countries. With its headquarters in Israel, Taro has established a strong presence in key pharmaceutical markets, offering a wide range of prescription and over-the-counter products. By consistently expanding its international operations and partnerships, Taro continues to serve patients in different regions and contribute to the advancement of healthcare globally.

Taro Pharmaceutical Industries Ltd has achieved several significant milestones in its history. The company has successfully developed and launched a wide range of generic pharmaceutical products, establishing a strong presence in various global markets. Taro has also demonstrated its commitment to quality and patient safety by achieving various regulatory approvals and certifications. Furthermore, the company has made significant strides in research and development, continuously innovating and introducing new therapies to improve patient outcomes. Taro Pharmaceutical Industries Ltd has consistently shown its dedication to the healthcare industry, making it a notable player in the global pharmaceutical market.

Taro Pharmaceutical Industries Ltd., established in 1950, is a leading global pharmaceutical company headquartered in Haifa Bay, Israel. With a rich history spanning over seven decades, Taro has evolved into a renowned manufacturer and marketer of high-quality prescription and over-the-counter pharmaceutical products. The company specializes in various therapeutic areas, including dermatology, cardiology, neurology, and more. Taro strives to provide patients worldwide with affordable and accessible medications to improve their quality of life. As a global player, Taro operates through subsidiaries, alliances, and distribution partnerships in multiple countries, demonstrating its commitment to global healthcare. Taro Pharmaceutical Industries Ltd. continuously explores innovative solutions and endeavors to meet the diverse healthcare needs of individuals worldwide.

The main competitors of Taro Pharmaceutical Industries Ltd in the market include global pharmaceutical companies such as Teva Pharmaceutical Industries Ltd, Mylan N.V., and Sun Pharmaceutical Industries Ltd. These companies compete with Taro Pharmaceutical Industries Ltd in the development, manufacturing, and marketing of generic and branded prescription pharmaceutical products. Their products may overlap in various therapeutic areas, creating competition in terms of cost, innovation, and market share.

Taro Pharmaceutical Industries Ltd is primarily active in the pharmaceutical industry.

Taro Pharmaceutical Industries Ltd is a leading company in the pharmaceutical industry. Their business model focuses on developing, manufacturing, and marketing high-quality prescription and over-the-counter medications. With a strong commitment to research and development, Taro aims to provide innovative solutions that meet the needs of patients around the world. By maintaining strict quality standards and adhering to regulatory guidelines, Taro ensures the safety and efficacy of their products. As a global company, Taro strives to expand its presence in various markets, offering a diverse portfolio of pharmaceutical products to maximize value for patients, healthcare professionals, and shareholders.

ניתן לחשב את מכפיל הרווח למניה נוכחית לא Taro Pharmaceutical Industries.

נכון לעכשיו לא ניתן לחשב את ה-KUV עבור Taro Pharmaceutical Industries.

תוצאת איכות AlleAktien עבור Taro Pharmaceutical Industries היא 2/10.

לא ניתן לחשב כרגע את ההכנסה עבור Taro Pharmaceutical Industries.

לא ניתן לחשב כרגע את הרווח עבור Taro Pharmaceutical Industries.

Taro Pharmaceutical Industries Ltd is a global pharmaceutical company based in Israel with operational offices in North America, Europe, and Asia. The company specializes in the production and marketing of pharmaceutical products, serving both the prescription and OTC markets. The company is divided into three main business segments: generics, branded products, and OTC products. The generics segment is the largest area of the company, focusing on the production of generic drugs in various therapeutic categories such as dermatology, cardiology, gastroenterology, and oncology therapies. Taro has a wide range of branded products marketed in the USA, Canada, and other countries worldwide. The portfolio includes specific medications for the treatment of skin conditions, eye infections, pain and inflammation, cardiovascular diseases, and other disorders. Taro's OTC product range offers a variety of products for pain relief, cold, flu, allergies, heartburn, and other health-related complaints. The company operates a highly vertically integrated production chain that spans from research and development to production, marketing, and distribution of their products. Taro has a global presence and is committed to developing innovative, high-quality products and providing cost-effective solutions. Taro works closely with its global customers to ensure continuous product availability and achieve a strong market presence. The company is dedicated to delivering high-quality medications and adheres to strict quality standards throughout the manufacturing process. In addition to its business activities, Taro actively participates in charitable projects and encourages its employees to engage in social initiatives. The company values sustainable development and strives to counteract the environmental impacts of its business operations. Overall, Taro Pharmaceutical Industries Ltd's business model is focused on strong vertical integration and global presence. The company offers a wide range of generics, branded products, and OTC products aimed at meeting the medical needs of customers worldwide. Taro is committed to developing innovative products and providing high-quality solutions while actively engaging in social and sustainable projects.

Taro Pharmaceutical Industries מחלקת דיבידנד בסכום של 0 USD במספר תשלומים במהלך השנה.

לא ניתן לחשב כרגע את הדיבידנד עבור Taro Pharmaceutical Industries או שהחברה אינה מפרישה דיבידנד.

ISIN של Taro Pharmaceutical Industries היא IL0010827181.

ה-WKN של Taro Pharmaceutical Industries הוא 897505.

הטיקר של Taro Pharmaceutical Industries הוא TARO.

במהלך 12 החודשים האחרונים, Taro Pharmaceutical Industries שילמה דיבידנד בגובה . זה מקביל לתשואת דיבידנד של כ-. ל-12 החודשים הקרובים, Taro Pharmaceutical Industries צפויה לשלם דיבידנד של 6.95 USD.

תשואת הדיבידנד של Taro Pharmaceutical Industries נוכחית היא .

Taro Pharmaceutical Industries משלמת דיבידנד רבעוני. הדיבידנד מתבצע בחודשים .

Taro Pharmaceutical Industries שילם דיבידנד כל שנה במשך ה-1 שנים האחרונות.

לתקופה הבאה של 12 חודשים ניתן לצפות לדיבידנדים בסך של 6.95 USD. זה מייצג תשואת דיבידנד של 16.17 %.

Taro Pharmaceutical Industries משויך למגזר 'בריאות'.

כדי לקבל את הדיבידנד האחרון של Taro Pharmaceutical Industries מתאריך 28.12.2018 בסך 12.86 USD, היה עליך להחזיק את המניה לפני היום המוקדם בתאריך 10.12.2018 בתיק.

תשלום הדיבידנד האחרון בוצע ב-28.12.2018.

בשנת 2023 שילמה Taro Pharmaceutical Industries 0 USD כדיבידנדים.

הדיבידנדים של Taro Pharmaceutical Industries מתחלקים ב-USD.